In your opinion, what is the benefit of Polatuzumab + R-CHP in the 1L treatment of patients with DLBCL?
M-BE-00002927
Polivy SmPC - 24/05/2022 : https://www.e-compendium.be/fr/notices/scientifique/7929/18885
M-BE-00002927
Polivy SmPC - 24/05/2022 : https://www.e-compendium.be/fr/notices/scientifique/7929/18885